对心力衰竭患者认知障碍的绘制研究:从2013年到2022年的文献分析分析
Qing Zhao1, Xuefen Zhu2, Xia Wan3
1Department of Cardiac Care Unit, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi Medical Center, Nanjing Medical University, Wuxi People's Hospital, Wuxi, 214023, China.
Heliyon
|October 21, 2024
概括
本文献分析揭示了过去十年心力衰竭患者认知障碍的关键研究趋势. 美国在出版物方面处于领先地位,其核心主题包括风险因素,干预和评估.
科学领域:
- 心脏病学 心脏病学
- 神经学 神经学
- 图书统计学 图书统计学
背景情况:
- 认知障碍是心力衰竭患者的一个重要问题.
- 心力衰竭和认知衰退之间的相互作用给研究带来了挑战.
研究的目的:
- 对心力衰竭患者认知障碍的研究进行全面的文献分析.
- 想象当前的研究环境,并识别新兴趋势.
主要方法:
- 在2013-2022年间发表的260篇文章的图书统计分析来自Web of Science.
- 使用CiteSpace和VOSviewer进行数据分析,包括关键字并发和突发检测.
- 微软Excel 2016被用于出版趋势分析.
主要成果:
- 在过去的十年中,年度出版物保持稳定.
- 美国以129个出版物领先;肯特州立大学和冈斯塔德约翰分别是顶级机构和作者.
- 确定的主要研究主题包括风险因素,干预措施,评估和认知障碍的机制.
结论:
- 这是关于这个主题的第一个文献计量研究,为未来的研究方向提供了洞察力.
- 这些发现使研究人员,临床医生和政策制定者能够提高对心力衰竭认知障碍的理解和干预措施.
相关概念视频
Heart Failure I: Introduction
1
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
1
Heart Failure V: Nursing Interventions
1
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
1
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
394
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
394
Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Heart Failure IV: Classification and Diagnostic Evaluation
1
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
1
Heart Failure Drugs: β-Blockers
320
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
320


